Company news
Chordia Therapeutics Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement Regarding the Reduction of Capital Reserve and Appropriation of Surplus
October 22, 2026
Fiscal year ended August 2026 Financial Results Presentation
October 15, 2026
Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2026 [Japanese GAAP]
October 15, 2026
Announcement Regarding AMED Grant Award for rogocekib (CTX-712)
September 29, 2026
Announcement Regarding Completion of Patient Enrollment in the Initial Expansion Cohort of rogocekib
September 24, 2026
Announcement of Orphan Drug Designation in Japan for rogocekib for Relapsed or Refractory AML
August 24, 2026
Announcement Regarding the Review Status of Orphan Drug Designation for Rogocekib, a CLK Inhibitor
July 28, 2026
Notice of Receipt of Grant
July 17, 2026
Non-consolidated Financial Results for the Nine Months Ended May 31 2026 [Japanese GAAP]
July 15, 2026
TABLE-Chordia Therapeutics - 6-MTH parent results
April 14, 2026
TABLE-Chordia Therapeutics - Q1 parent results
January 14, 2026
TABLE-Chordia Therapeutics -2024/25 parent results
October 13, 2025
Decks
- FY2026 Earnings Presentation
Earnings · 27 slides · Oct 15, 2026
- FY2026 Earnings Presentation
Earnings · 27 slides · Oct 15, 2026